Dr. Robertson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
705 Riley Hospital Dr
Roc 4340
Indianapolis, IN 46202Phone+1 317-944-5611Fax+1 317-944-3107
Education & Training
- University of WashingtonFellowship, Pediatric Hematology/Oncology, 1987 - 1990
- University of WashingtonResidency, Pediatrics, 1984 - 1987
- University of Wisconsin Hospitals and ClinicsFellowship, Medical Oncology, 1983 - 1984
- University of Wisconsin Hospitals and ClinicsInternship, Internal Medicine, 1982 - 1983
- University of Wisconsin School of Medicine & Public HealthClass of 1982
Certifications & Licensure
- IN State Medical License 1993 - 2025
- WA State Medical License 1985 - 1994
- American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- Fellow (FAAP) American Academy of Pediatrics
Clinical Trials
- Pilot Study of Gleevec/Imatinib Mesylate (STI-571, NSC 716051) in Neurofibromatosis (NF1) Patient With Plexiform Neurofibromas Start of enrollment: 2012 Feb 01
- Cabozantinib for Plexiform Neurofibromas (PN) in Subjects With NF1 in Children and Adults Start of enrollment: 2014 Jun 01
- Study of Imatinib in Children With Neurofibromatosis and Airway Tumors Start of enrollment: 2018 Sep 01
Publications & Presentations
PubMed
- 39 citationsCabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial.Michael Fisher, Chie-Schin Shih, Steven D. Rhodes, Amy E. Armstrong, Pamela L. Wolters
Nature Medicine. 2021-01-13 - 5 citationsImage segmentation of plexiform neurofibromas from a deep neural network using multiple b-value diffusion data.Chang Y. Ho, John M. Kindler, Scott A. Persohn, Stephen F. Kralik, Kent A. Robertson
Scientific Reports. 2020-10-20 - 2 citationsEarly administration of imatinib mesylate reduces plexiform neurofibroma tumor burden with durable results after drug discontinuation in a mouse model of neurofibromat...Amy E. Armstrong, Steven D. Rhodes, Abbi Smith, Shi Chen, Waylan K. Bessler
Pediatric Blood & Cancer. 2020-08-01
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: